Aparasu R. R., Mort J. R. and Brandt H. (2003). Psychotropic prescription use by community-dwelling elderly in the United States. Journal of the American Geriatrics Society, 51, 671–677.
Bell J. S., Väänänen M., Ovaskainen H., Närhi U. and Airaksinen M. S. (2007). Providing patient care in community pharmacies: practice and research in Finland. Annals of Pharmacotherapy, 41, 1039–1046.
Bell J. S., Klaukka T., Ahonen J. and Hartikainen S. (2009). National utilization of transdermal fentanyl among community-dwelling older people in Finland. American Journal of Geriatric Pharmacotherapy, 7, 355–361.
Dorsey E. R., Rabbani A., Gallagher S. A., Conti R. M. and Alexander G. C. (2010). Impact of FDA black box advisory on antipsychotic medication use. Archives of Internal Medicine, 170, 96–103.
Draper B. and Berman K. (2008). Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs and Aging, 25, 501–519.
Folstein M. F., Folstein S. E. and McHugh P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Fox C. B., Treadway A. K., Blaszczyk A. T. and Sleeper R. B. (2009). Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly. Pharmacotherapy, 29, 383–397.
Hartikainen S., Rahkonen T., Kautianen H. and Sulkava R. (2003). Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? International Clinical Psychopharmacology, 18, 163–167.
Hartikainen S. A., Mantyselka P., Louhivuori-Laako K., Enlund H. and Sulkava R. (2005). Concomitant use of analgesics and psychotropics in home-dwelling elderly people – Kuopio 75+ study. British Journal of Clinical Pharmacology, 60, 306–310.
Hartikainen S., Lönnroos E. and Louhivuori K. (2007). Medication as a risk factor for falls: critical systematic review. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 62, 1172–1181.
Hilmer S. N., McLachlan A. J. and Le Couteur D. G. (2007). Clinical pharmacology in the geriatric patient. Fundamental and Clinical Pharmacology, 21, 217–230.
Jyrkkä J., Enlund H., Korhonen M. J., Sulkava R. and Hartikainen S. (2009). Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs and Aging, 26, 494–503.
Lawton M. P. and Brody E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9, 179–186.
Linjakumpu T. A., Hartikainen S. A., Klaukka T. J., Koponen H. J., Kivela S-L. and Isoaho R. E. (2002). Psychotropics among the home dwelling elderly: increasing trends. International Journal of Geriatric Psychiatry, 17, 874–883.
O'Bryant S. E. et al. (2008). Detecting dementia with the mini-mental state examination in highly educated individuals. Archives of Neurology, 65, 963–967.
Pokela N., Bell J. S., Lihavainen K., Sulkava R. and Hartikainen S. (2010). Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. American Journal of Geriatric Pharmacotherapy, 8, 233–244.
Rikala M., Hartikainen S., Sulkava R. and Korhonen M. J. (2010a). Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly Finns: a population-based intervention study. Drugs and Aging, 27, 337–349.
Rikala M., Korhonen M. J., Sulkava R. and Hartikainen S. (2010b). The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. International Psychogeriatrics, 23, 473–484.
Salonoja M., Salminen M., Aarnio P., Vahlberg T. and Kivelä S. L. (2010). One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age and Ageing, 39, 313–319.
Schneider L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
Snowdon J. and Fleming R. (2008). Recognising depression in residential facilities: an Australian challenge. International Journal of Geriatric Psychiatry, 23, 295–300.
Sonnenberg C. M., Deeg D. J., Comijs H. C., van Tilburg W. and Beekman A. T. (2008). Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years. Journal of Affective Disorders, 211, 299–305.
Soudry A., Dufouil C., Ritchie K., Dartigues J. F., Tzourio C. and Alpérovitch A. (2008). Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study. European Journal of Clinical Pharmacology, 64, 51–59.
van Vliet P., van der Mast R. C., van den Broek M., Westendorp R. G. and de Craen A. J. (2009). Use of benzodiazepines, depressive symptoms and cognitive function in old age. International Journal of Geriatric Psychiatry, 24, 500–508.
Verdoux H., Tournier M. and Bégaud B. (2010). Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica, 121, 4–10.
Watanabe N. et al. (2010). Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs, 24, 35–53.
Yesavage J. A. et al. (1982–1983). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 37–49.
Zhang Y. et al. (2010). Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics, 22, 437–444.